This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

AcelRx Pharmaceuticals Inc (ACRX)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 88.40M 47.93M 7.79M 3.06M
Receivables 0.00 0.00 0.00 0.00
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 104.56M 61.77M 38.15M 5.78M
Property, Plant & Equipment, Gross 7.28M 4.00M 4.36M 2.35M
Accumulated Depreciation & Depletion 2.10M 1.51M 2.05M 1.55M
Property, Plant & Equipment, Net 5.18M 2.48M 2.31M 800.00K
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 292.00K 269.00K 383.00K 251.00K
Total Non-Current Assets 5.47M 2.75M 2.69M 1.05M
Liabilities & Shareholder Equity
Total Assets 110.03M 64.52M 40.84M 6.83M
Accounts Payable 2.34M 2.24M 1.53M 543.00K
Short Term Debt 0.00 7.44M 3.80M 12.01M
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 6.87M 14.33M 7.84M 13.41M
Long Term Debt 14.36M 8.53M 15.28M 0.00
Deferred Income Taxes 188.00K 312.00K 15.00K 0.00
Other Non-Current Liabilities 15.45M 7.50M 232.00K 3.37M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 30.00M 16.34M 15.52M 59.31M
Total Liabilities 36.87M 30.67M 23.37M 72.72M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 73.16M 33.85M 17.47M -65.89M
Common Par 43.00K 37.00K 22.00K 3.00K
Additional Paid In Capital 218.57M 155.84M 106.11M 2.67M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -145.45M -122.03M -88.66M -68.56M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 1.00K 1.00K 0.00 0.00
Total Capitalization 87.52M 42.38M 32.74M -65.89M
Total Equity 73.16M 33.85M 17.47M -65.89M
Total Liabilities & Stock Equity 110.03M 64.52M 40.84M 6.83M
Total Common Shares Outstanding 43.05M 37.06M 19.57M 19.37M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 39.75M 22.12M 17.34M 656.65K
Diluted Weighted Shares Outstanding 39.75M 22.12M 17.34M 656.65K
Number of Employees 27 25 21 19
Number of Part-Time Employees 0 0 0 0
ACRX News

ACRX AcelRx Pharmaceuticals Inc

Analysts Ratings for ACRX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 3 3 4 5
Moderate Buy 1 1 0 0
Hold 2 2 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET ACRX ANALYST REPORT

Brokerage Partners

ACRX Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs